Is the price fair?
What LMAT's price assumes
LeMaitre Vascular, Inc. trades at 29.4× earnings against 42.5× for the median Medical Instruments & Supplies name, cheaper than its own group.
29.4
Trailing P/E · Medical Instruments & Supplies median 42.5 · cheaper than the typical name in its group
- Price / sales
- 9.79
Price / sales · as of 2026-Q1
- Free cash flow yield
- 3.7%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +9.7%
Growth the price implies · The price pays for +9.7% free cash flow growth a year for a decade; the business has delivered +63% a year over the last three.
Details›
- Price / book2026-Q1
- 6.17
- Healthcare median P/E362 names
- 31.5
- Medical Instruments & Supplies median P/E29 names
- 42.5
- Free cash flow, trailing twelve months
- $79M
- Market capitalisation
- $2.15B
- 3-year free cash flow growth
- +63%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $91.79 |
| Its own P/E history, median | $105.56 |
| Its own P/E history, upper quartile | $120.63 |
| 52-week range | $78.80 – $117.10 |
| Today | $79.58 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #9 of 27 by Smart Score